Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
This randomized clinical trial studies a group-based lifestyle intervention or usual care in measuring biomarker levels in participants at high risk for breast cancer. Studying the effects that changes to daily eating and exercise habits can have on the body's hormone levels and the body's ability to activate proteins may help doctors identify interventions for individuals at high risk for breast cancer.
Full description
PRIMARY OBJECTIVES:
I. To calculate eligibility rates, participation rates, retention, and adherence within the Diet, Exercise and Estrogen Metabolites (DEEM) study.
II. To determine inter- and intra-person variability of the estrogen-deoxyribonucleic acid (DNA) adducts (EDA) biomarkers in participants of the DFS.
III. To explore the effects of the intervention on percent adiposity and the EDA ratio at the end of the 3-month intervention and 6-month follow-up.
SECONDARY OBJECTIVES:
I. To explore the effects of the intervention on the DNA damage repair (DDR) biomarker at 3-months.
OUTLINE: Participants are randomized to 1 of 2 arms.
ARM I: Participants take part in weekly 2-hour group counseling sessions for 6 months with taper beginning at 3 months. Group sessions include education, group process, and experiential learning on the benefits of physical activity, balanced nutrition, and mindfulness techniques. Participants set goals for changing their dietary habits with the help of a mental health counselor and are also encouraged to exercise 3-4 times per week, including experiential group activities such as brisk walking, yoga, Zumba, and group fitness.
ARM II: Participants receive their usual care and are also provided with study materials on healthy diet and exercise at the end of the study.
After completion of study, participants are followed up for 3 months.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Women will be considered at high risk for developing breast cancer if they fulfill one of the following criteria:
Body mass index (BMI)
Willingness to provide informed consent
Physically able to undertake a moderate exercise program (assessed at the clinic visit)
Participant has the ability to attend weekly group counseling sessions and subsequent clinic visits
Participant has the ability to communicate in English
Participant agrees to be randomly assigned
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
17 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal